MDNA11
To learn more about our ongoing clinical trial or to find out if a trial is enrolling patients in your area, please visit www.clinicaltrials.gov.
Candidate | Phase | Study Number | Study Title |
---|---|---|---|
MDNA11 | 1/2 | NCT05086692 | ABILITY – Advanced solid tumors |
At this time, Medicenna’s investigational therapy is not available on an expanded access or right-to-try basis for new patients. In the event Medicenna decides to consider expanded access or right-to-try use, the Company will evaluate and respond to each request that it receives on a case-by-case basis.